Publication

Helicobacter pylori modulated host immunity in gastric cancer patients with S-1 adjuvant chemotherapy

Koizumi Y, Ahmad S, Ikeda M, Yashima-Abo A, Espina G, Sugimoto R, Sugai T, Iwaya T, Tamura G, Koeda K, Liotta LA, Takahashi F, Nishizuka SS; Northern Japan Gastric Cancer Study Consortium.

J Natl Cancer Inst. 2022 Apr 19;djac085. doi: 10.1093/jnci/djac085. Online ahead of print.

PMID:35437596

Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma

Kogo R, Manako T, Iwaya T, Nishizuka S, Hiraki H, Sasaki Y, Idogawa M, Tokino T, Koide A, Komune N, Yasumatsu R, Nakagawa T.

Cancer Med. 2022 Mar 30. doi: 10.1002/cam4.4726. Online ahead of print.

PMID: 35352507

Editorial Comment to “A nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients”

Yashima-Abo A, Otsuka K, Nishizuka SS.

Ann Surg Oncol. 2021 Oct;28(11):5818-5819. doi: 10.1245/s10434-021-10328-z. Epub 2021 Jun 24.

PMID:34165654

Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

Fujisawa R, Iwaya T, Endo F, Idogawa M, Sasaki N, Hiraki H, Tange S, Hirano T, Koizumi Y, Abe M, Takahashi T, Yaegashi M, Akiyama Y, Masuda M, Sasaki A, Takahashi F, Sasaki Y, Tokino T, Nishizuka SS.

Carcinogenesis. 2021 Sep 24:bgab088. doi: 10.1093/carcin/bgab088. Epub ahead of print.

PMID:34559206

Reply

Iwaya T, Nishizuka SS.

Gastroenterology. 2021 Jul;161(1):367-368. doi:10.1053/j.gastro.2021.03.033. Epub 2021 Mar 22.

PMID:33766565

Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling

Yaegashi M, Iwaya T, Sasaki N, Fujita M, Ju Z, Siwak D, Hachiya T, Sato K, Endo F, Kimura T, Otsuka K, Sugimoto R, Sugai T, Liotta L, Lu Y, Mills GB, Nakagawa H, Nishizuka SS.

Br J Cancer. 2021 Apr;124(9):1556-1565. doi:10.1038/s41416-021-01266-4. Epub 2021 Mar 3.

PMID:33658639

Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction

Iwaya T, Endo F, Takahashi F, Tokino T, Sasaki Y, Nishizuka SS.

Gastroenterology. 2021 Jan;160(1):463-465.e4.

PMID:33011175

Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA

Sasaki N, Iwaya T, Chiba T, Fujita M, Ju Z, Endo F, Yaegashi M, Hachiya T, Sugimoto R, Sugai T, Siwak DR, Liotta LA, Lu Y, Mills GB, Nakagawa H, Nishizuka SS.

PLoS One. 2020 Oct 7;15(10):e0239966. doi: 10.1371/journal.pone.0239966. eCollection 2020.

PMID:33027286

Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer

Lin Y, Nakatochi M, Hosono Y, Ito H, Kamatani Y, Inoko A, Sakamoto H, Kinoshita F, Kobayashi Y, Ishii H, Ozaka M, Sasaki T, Matsuyama M, Sasahira N, Morimoto M, Kobayashi S, Fukushima T, Ueno M, Ohkawa S, Egawa N, Kuruma S, Mori M, Nakao H, Adachi Y, Okuda M, Osaki T, Kamiya S, Wang C, Hara K, Shimizu Y, Miyamoto T, Hayashi Y, Ebi H, Kohmoto T, Imoto I, Kasugai Y, Murakami Y, Akiyama M, Ishigaki K, Matsuda K, Hirata M, Shimada K, Okusaka T, Kawaguchi T, Takahashi M, Watanabe Y, Kuriki K, Kadota A, Okada R, Mikami H, Takezaki T, Suzuki S, Yamaji T, Iwasaki M, Sawada N, Goto A, Kinoshita K, Fuse N, Katsuoka F, Shimizu A, Nishizuka SS, Tanno K, Suzuki K, Okada Y, Horikoshi M, Yamauchi T, Kadowaki T, Yu H, Zhong J, Amundadottir LT, Doki Y, Ishii H, Eguchi H, Bogumil D, Haiman CA, Le Marchand L, Mori M, Risch H, Setiawan VW, Tsugane S, Wakai K, Yoshida T, Matsuda F, Kubo M, Kikuchi S, Matsuo K.

Nat Commun. 2020 Jun 24;11(1):3175.

PMID:32581250

Affected medical services in Iwate prefecture in the absence of a COVID-19 outbreak

Sasaki N, and Nishizuka SS.

medRxiv 2020.06.19.20135269.

PMID:

RPPAs for cell subpopulation analysis

Kume K, Nishizuka SS.

Adv Exp Med Biol. 2019;1188:227-237.

PMID:31820391

Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms

Ohmori Y, Nomura T, Fukushima N, Takahashi F, Iwaya T, Koeda K, Nishizuka SS; Members of the Northern Japan Gastric Cancer Study Consortium.

J Surg Oncol. 2019 Dec;120(7):1154-1161.

PMID:31578743

A pipeline for ctDNA detection following primary tumor profiling using a cancer-related gene sequencing panel

Nishizuka SS, Sato KA, Hachiya T.

Methods Mol Biol. 2019;1908:229-241.

PMID:30649732

Liver regeneration supported by Muse cells

Nishizuka SS, Suzuki Y, Katagiri H, Takikawa Y.

Adv Exp Med Biol. 2018;1103:219-241.

PMID:30484232

Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy

Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, Iwaya T, Takahashi T, Koeda K; Northern Japan Gastric Cancer Study Consortium.

J Surg Oncol. 2018 Apr;117(5):947-956.

PMID:29355977

Colony lysate arrays for proteomic profiling of drug-tolerant persisters of cancer cell

Kume K and Nishizuka SS.

Anal Chem 2017; 89(17):8626-31.

PMID:28753272

Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer

Ito C, Nishizuka SS, Ishida K, Uesugi N, Sugai T, Tamura G, Koeda K, Sasaki A.

cancer. J Surg Res. 2017 May 15;212:195-204.

PMID:28550907

Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil

Ishida K, Ito C, Ohmori Y, Kume K, Sato KA, Koizumi Y, Konta A, Iwaya T, Nukatsuka M, Kobunai T, Takechi T, Nishizuka SS.

Sci Rep. 2017 May 23;7(1):2262.

PMID:28536445

Ductular reactions in the liver regeneration process with local inflammation after physical partial hepatectomy

Suzuki Y, Katagiri H, Wang T, Kakisaka K, Kume K, Nishizuka SS, Takikawa Y.

Lab Invest 2016; 97.

PMID:27617400

Importance of metabolic rate to the relationship between the number of genes in a functional category and body size in Peto’s paradox for cancer

Takemoto K, Ii M, Nishizuka SS.

R Soc Open Sci. 2016 Sep 7;3(9):160267.

PMID:27703689

α-Amanitin restrains cancer relapse from drug-tolerant cell subpopulations via TAF15

Kume K, Ikeda M, Miura S, Ito K, Sato KA, Ohmori Y, Endo F, Katagiri H, Ishida K, Ito C, Iwaya T, Nishizuka SS.

Sci Rep 2016; 6:25895.

PMID:27181033

New era of integrated cancer biomarker discovery using reverse-phase protein arrays

Nishizuka SS, Mills GB.

Drug Metab Pharmacokinet. 2016 Feb;31(1):35-45.

PMID:26822993

Individualized mutation detection in circulating tumor DNA for monitoring colorectal tumor burden using a cancer-associated gene sequencing panel

Sato KA, Hachiya T, Iwaya T, Kume K, Matsuo T, Kawasaki K, Abiko Y, Akasaka R, Matsumoto T, Otsuka K, Nishizuka SS.

PLoS One. 2016 Jan 4;11(1):e0146275.

PMID:26727500

A distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components

Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, Endo F, Kume K, Takahara T, Nitta H, Tsuda H, Dezawa M, Nishizuka SS.

Am J Transplant 2016; 16:468-83.

PMID:26663569

Systematic protein level regulation via degradation machinery induced by genotoxic drugs

Kume K, Ishida K, Ikeda M, Takemoto K, Shimura T, Young L, Nishizuka SS.

J Proteome Res 2016; 15:205-15.

PMID:26625007

Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society

Akbani R, Becker KF, Carragher N, Goldstein T, de Koning L, Korf U, Liotta L, Mills GB, Nishizuka SS, Pawlak M, Petricoin EF 3rd, Pollard HB, Serrels B, Zhu J.

Mol Cell Proteomics 2014; 13:1625-43.

PMID:24777629

A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines

Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.

PLos One 2014; 9:e90155.

PMID:24587255

Evaluation of chemosensitivity prediction using quantitative dose-response curve classification for highly advanced/relapsed gastric cancer

Matsuo T, Nishizuka SS*, Ishida K, Endo F, Katagiri H, Kume K, Ikeda M, Koeda K, Wakabayashi G.

World J Surg Oncol 2013;11:11.

PMID:23339659

Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers

shida K, Nishizuka SS*, Chiba T, Ikeda M, Kume K, Endo F, Katagiri H, Matsuo T, Noda H, Iwaya T, Yamada N, Fujiwara H, Takahashi M, Itabashi T, Uesugi N, Maesawa C, Tamura G, Sugai T, Otsuka K, Koeda K, Wakabayashi G.

PLoS One 2012;7:e43236.

PMID:22905237

Reverse-phase protein lysate microarray (RPA) for the experimental validation of quantitative protein network models

Nishizuka SS*.

Methods Mol Biol 2011;785:65-77.

PMID:21901594

Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models

Matsuo T, Nishizuka SS*, Ishida K, Iwaya T, Ikeda M, Wakabayashi G.

BMC Res Notes 2011;4:140.

PMID:21554739